|
Net Sales by Product Categories (Consolidated)
| |
FYE 3/2009
|
FYE 3/2010
|
FYE 3/2011 *
|
FYE 3/2012
1st Half |
| General Hospital Business |
146,496 |
149,788 |
152,945 |
73,992 |
| %YoY |
-3.6% |
2.2% |
2.3% |
-4.3% |
| Cardiac & Vascular Business |
127,034 |
135,831 |
144,415 |
79,237 |
| %YoY |
1.8% |
6.9% |
6.1% |
10.4% |
| Blood Transfusion Business |
23,871 |
23,947 |
24,603 |
35,293 |
| %YoY |
1.4% |
0.3% |
2.7% |
183.0% |
| Consumer Health-care Business |
5,344 |
6,442 |
4,326 |
2,195 |
| %YoY |
-11.9% |
20.5% |
-32.8% |
5.1% |
| Total |
302,746 |
316,009 |
326,291 |
190,718 |
| %YoY |
-1.2% |
4.4% |
3.3% |
16.5% |
| Average exchage rate (yen) US$ |
100.71 |
92.89 |
85.74 |
79.75 |
| Average exchage rate (yen) EUR |
144.07 |
131.18 |
113.13 |
113.74 |
- * Including impact of accounting period adjustment of overseas subsidiaries.
Histroical Data
Net Sales by region
| |
FYE 3/2009
|
FYE 3/2010
|
FYE 3/2011
|
FYE 3/2012
1st Half |
| Japan |
162,049 |
173,910 |
177,132 |
92,392 |
| %YoY |
|
7.3% |
1.9% |
3.3% |
| Europe |
55,962 |
56,590 |
56,630 |
36,525 |
| %YoY |
|
1.1% |
0.1% |
33.6% |
| Americas |
53,770 |
53,776 |
56,977 |
39,031 |
| %YoY |
|
0.0% |
6.0% |
36.0% |
| Asia and others |
30,964 |
31,731 |
37,474 |
22,768 |
| %YoY |
|
2.5% |
18.1%
* |
23.7% |
| Total |
302,746 |
316,009 |
328,214 |
190,718 |
| %YoY |
-1.2% |
4.4% |
3.9% |
16.3% |
| Outside of Japan Sales to Net Sales |
46.5% |
45.0% |
46.0% |
51.6% |
- * Including impact of accounting period adjustment of overseas subsidiaries.
* Grouping partly updated.
|
12KB